After conjugation with a-EGFR (a monoclonal antibody derivative), Ag NPLs were readily taken up by EGFR-overexpressing pancreatic cancer cells by receptor-mediated endocytosis and exhibited little or no toxicity. Here, EGFR is linked to pancreatic neoplasm.